The board of directors of Egyptian International Pharmaceutical Industries Company (EIPICO), Egypt, has approved the initial feasibility study on proceeding with the legal procedures to establish an Egyptian joint-stock company.
That’s to manufacture pharmaceutical raw materials in the Suez Canal Economic Zone (SCzone).
The company stated that the issued capital will be about EGP one billion.
The paid-in capital is estimated at EGP 400 million, with EPICO’s share of 25%.